Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1998
11/19/1998WO1998051302A1 Composition and methods for treating alzheimer's disease and other amyloidoses
11/19/1998WO1998051300A1 Treatment of allergic conditions
11/19/1998WO1998051283A1 Topical compositions
11/19/1998WO1998035061A3 Member of the tnf family useful for treatment and diagnosis of disease
11/19/1998WO1998033896A3 Microorganisms with increased production of clavulanic acid
11/19/1998CA2290477A1 Polynucleotides encoding a cd53-like transmembrane protein
11/19/1998CA2290021A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998CA2289966A1 Topical compositions
11/19/1998CA2289720A1 Hgf polypeptides and their use in therapy
11/19/1998CA2289550A1 Pharmaceutical antiviral composition comprising glycyrrhizic acid and at least one protein endowed with antiviral activity
11/19/1998CA2288599A1 Tumor-associated antigen
11/19/1998CA2288117A1 Tissue factor for influencing blood vessel formation
11/19/1998CA2287839A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions
11/19/1998CA2268848A1 Hiv and cancer treatment
11/18/1998EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998EP0877759A1 Methods for increasing endogenous levels of corticotropin-releasing factor
11/18/1998EP0877758A2 PURIFIED SR-p70 PROTEIN
11/18/1998EP0877750A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents
11/18/1998EP0877627A1 Obesity protein analog compounds and formulations thereof
11/18/1998EP0877621A1 Combined pharmaceutical preparation containing lhrh-analogous substances and anti-estrogens for treating gynaecological disorders
11/18/1998EP0877613A2 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
11/18/1998EP0877608A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS
11/18/1998EP0877605A2 Solid instant-release forms of administration and process for producing the same
11/18/1998EP0877601A1 Combination injection preparation
11/18/1998EP0877599A1 Sustained delivery of an active agent using an implantable system
11/18/1998EP0877549A1 Methods and compositions for the reduction of xenotransplantation rejection
11/18/1998CN1199336A Method to increase retinal blood flow
11/18/1998CN1199334A Long-lasting composition for rectal administration
11/17/1998US5837815 Amino acid sequences with phosphorylation activity
11/17/1998US5837736 Oxygen-free administration to tumors
11/17/1998US5837730 Reducing the side-effect of glycine for treating nervous system disorder, psychological disorder
11/17/1998US5837493 Human galectins
11/17/1998US5837451 Identifying composition which affect kinase activity
11/17/1998US5837291 Enteric preparation coated with a non-solvent enteric coating agent using a liquid plasticizer
11/17/1998US5837286 Taste masking for unplatable formulations
11/17/1998US5837283 Cationic lipid compositions targeting angiogenic endothelial cells
11/17/1998US5837279 Encapsulation of ionizable agents in liposomes
11/17/1998US5837269 Vaccine compositions and method for enhancing an immune response
11/17/1998US5837266 Composition, barrier film, and method for preventing contact dermatitis
11/17/1998US5837252 Extraction with acetone reducing nordihydroguaiaretic quinone present by ascorbic acid
11/17/1998US5837224 Method of inhibiting photoaging of skin
11/13/1998CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998WO1998050540A1 MODIFIED ANTISENSE NUCLEOTIDES COMPLEMENTARY TO A SECTION OF THE HUMAN Ha-Ras GENE
11/12/1998WO1998050434A1 Methods for eosinophil depletion and compositions therefor
11/12/1998WO1998050432A1 Recombinant antibody-enzyme fusion proteins
11/12/1998WO1998050424A2 Human serine protease precursor
11/12/1998WO1998050080A1 Methods of screening compounds useful for prevention of infection or pathogenicity
11/12/1998WO1998050075A1 Cox-2 inhibitors in combination with nmda-blockers for treating pain
11/12/1998WO1998050074A2 Compositions of antichlamydial agents for the diagnosis and management of infection caused by chlamydia
11/12/1998WO1998050073A1 Integrin ligand, human mindin
11/12/1998WO1998050066A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998WO1998050064A2 Adhesion prevention and an endoscopic insufflation system therefor
11/12/1998WO1998050063A1 Method of treating hyperprolactinemia and prolactinomas
11/12/1998WO1998050059A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998WO1998050050A1 Covalently linked n,o-carboxymethylchitosan and uses thereof
11/12/1998WO1998050048A1 Aplidine as an l-type calcium channel enhancer
11/12/1998WO1998050047A1 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
11/12/1998WO1998050046A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998WO1998050044A1 Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
11/12/1998WO1998050039A1 Use of misoprostol or/and misoprostol acid for preparing drug in order to cure erectile dysfunction
11/12/1998WO1998050034A1 Internal two photon excitation device for delivery of pdt to diffuse abnormal cells
11/12/1998WO1998050028A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/12/1998WO1998050027A1 Method of improving disturbed behavior and elevating mood in humans
11/12/1998WO1998050019A1 Stable oral pharmaceutical dosage forms
11/12/1998WO1998050018A1 Drug delivery system
11/12/1998WO1998050014A1 Topical administration of catecholamines and related compounds to subcutaneous muscle tissue using percutaneous penetration enhancers
11/12/1998WO1998049970A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis
11/12/1998WO1998031707A3 Transgenic animals with disrupted npy y1 receptor genes
11/12/1998CA2289731A1 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists
11/12/1998CA2289548A1 Method for preventing gastritis using amylin or amylin agonists
11/12/1998CA2289228A1 Diagnosis and management of infection caused by chlamydia
11/12/1998CA2289190A1 Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
11/12/1998CA2289125A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998CA2289124A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998CA2289115A1 Recombinant antibody-enzyme fusion proteins
11/12/1998CA2289025A1 Human serine protease precursor
11/12/1998CA2288946A1 Modified antisense nucleotides complementary to a section of the human ha-ras gene
11/12/1998CA2288876A1 Drug delivery system
11/12/1998CA2288693A1 Method of improving disturbed behavior and elevating mood in humans
11/12/1998CA2288639A1 Aplidine as an l-type calcium channel enhancer
11/12/1998CA2288149A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis
11/12/1998CA2288017A1 Methods for eosinophil depletion and compositions therefor
11/12/1998CA2287774A1 Methods of screening compounds useful for prevention of infection or pathogenicity
11/12/1998CA2286341A1 Mtp inhibitors and fat soluble vitamin therapeutic combinations to lower serum lipid levels
11/12/1998CA2285419A1 Internal two photon excitation device for delivery of pdt to diffuse abnormal cells
11/11/1998EP0877083A1 A novel human G-protein coupled receptor (HCEPT09)
11/11/1998EP0877030A2 EPO primary response gene 1,(EPRG1)
11/11/1998EP0876613A1 Treatment and diagnosis of infections due to helicobacter pylori
11/11/1998EP0876611A1 Molecules that home to a selected organ or tissue in vivo and methods of identifying same
11/11/1998EP0876491A1 A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 AND ITS ASSOCIATION WITH minK
11/11/1998EP0876485A2 NOVEL CREBa ISOFORM
11/11/1998EP0876482A1 Il-13 receptor polypeptide
11/11/1998EP0876396A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX
11/11/1998EP0876387A1 Method to improve the biological and antiviral activity of protease inhibitors
11/11/1998EP0876160A2 Ligand directed enzyme prodrug therapy
11/11/1998EP0876158A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms
11/11/1998EP0876146A1 Nucleoside analogs in combination therapy of herpes simplex infections
11/11/1998EP0876141A2 Preparations of non-steroidal analgesics
11/11/1998EP0876140A2 Improved concentrated injection and infusion solutions for intravenous administration
11/11/1998CN1198775A Recombinant c-proteinase and processes, methods and uses thereof
1 ... 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 ... 1151